News

UofL closes on purchase of KentuckyOne's Louisville-area assets

UofL closes on purchase of KentuckyOne's Louisville-area assets

Workers prepare to make sign changes to Our Lady of Peace, now known as UofL Health - Peace Hospital.

The University of Louisville has completed its acquisition of KentuckyOne Health’s Louisville-area portfolio, ending two years of uncertainty about the future of Jewish Hospital and the other health care assets.

The transition of ownership from KentuckyOne’s parent company, CommonSpirit Health, to the university’s UofL Health affiliate is effective Nov. 1. Some 5,500 former KentuckyOne employees have now joined UofL and UofL Health, which has assumed management of the assets.

“This is an exciting and historic day for the University of Louisville,” said UofL President Neeli Bendapudi. “This acquisition enables us to ensure access to quality health care for our entire community, and it strengthens our School of Medicine and our Health Sciences Center campus by allowing us to offer more training opportunities for our students and more research capacity for our faculty. It also saves thousands of jobs that could have been lost if any of these facilities closed.”

UofL is acquiring the KentuckyOne assets with the promise of a critical $50 million, 20-year loan from the Kentucky Economic Development Finance Authority. Half of that loan would be forgiven if the university meets certain criteria in terms of employment or service to underserved areas. The Jewish Heritage Fund for Excellence and the Jewish Hospital and St. Mary’s Foundation also are investing in the deal, contributing $10 million and $40 million, respectively.

“We owe such a debt of gratitude to our partners—Gov. Matt Bevin, the leadership of the House and Senate and these foundations—for making this transaction a reality,” Bendapudi said. She also thanked the Sisters of Charity of Nazareth and leaders of the local Jewish community for the legacy of care they have created over more than a century of work in the Louisville community.

The purchase includes:

·         Jewish Hospital, including the Outpatient Center, Rudd Heart and Lung Center, offices and parking garages;

·         Frazier Rehabilitation Institute;

·         Sts. Mary and Elizabeth Hospital;

·         Our Lady of Peace;

·         Jewish Hospital Shelbyville;

·         Jewish Medical Centers East, Northeast, South and Southwest;

·         Physicians groups affiliated with KentuckyOne.

All of the assets will be rebranded under the UofL Health umbrella.

“Today marks an important moment for the future of health care in the Louisville community, and I want to thank everyone who contributed to the successful completion of this transition,” said Larry Schumacher, Senior Vice President of Operations, Southeast Division, CommonSpirit Health. “As we transfer the ownership and operations to UofL Health, I am optimistic that these facilities will continue their legacy of excellence and innovation led by the outstanding employees and providers.”

                                                      

 

UofL faculty develop and license specialized treadmill for children with spinal cord injuries

Medicine, engineering work together to build custom tool for successful therapy
UofL faculty develop and license specialized treadmill for children with spinal cord injuries

The old treadmill system, left. The new, specially designed treadmill system, right.

Children with spinal cord injuries have experienced remarkable results in recovery at the University of Louisville and Frazier Rehab Institute through locomotor training, a therapy designed to help them recover the ability to sit, stand and even walk. In locomotor training, the child is suspended over a treadmill and his or her feet are moved by trainers in a stepping motion. This taps into capability of the spinal cord to help the child regain movement and trunk control.

Andrea Behrman, Ph.D., of the UofL Department of Neurological Surgery and the Kentucky Spinal Cord Injury Research Center (KSCIRC), pioneered the use of locomotor training in children at UofL since 2012. Until now, however, Behrman’s team has used treadmills and harnesses designed for adults that have been adapted for children. The oversized equipment is cumbersome for children and working on cut-down adult-sized devices has resulted in unnecessary strain for the trainers and therapists who work with them.

So Behrman enlisted Tommy Roussel, Ph.D. of the Department of Bioengineering at UofL, to engineer a treadmill and harness system specifically for young children. Using engineering expertise, user feedback and a patent held by Susan Harkema, Ph.D., professor of neurosurgery and pioneer in spinal cord injury research in adults at UofL, a new treadmill was designed from the ground up just for children. [See video]

“It was kind of like putting a kid on an adult bicycle or watching kids play basketball with a ten-foot goal,” Roussel said. “So we have redesigned the system with the same operational capacity but with kids in mind.”

The new pediatric treadmill has multiple advantages for both children and trainers:

  • Suspension tower is located behind the child on the treadmill so therapists can more easily and directly engage with the child
  • Narrower tread, focusing the child’s steps and bringing trainers closer to the child’s legs and feet
  • Trainers’ seats are more appropriately positioned closer to the child and are adjustable to accommodate trainers of different heights
  • Treadmill tower swivels to allow the child to be hoisted from a wheelchair and onto the treadmill
  • Smaller, more adaptable harness that is more comfortable and easier to adjust to the child’s changing capability

“The treadmill is a tool for us, but we want it to be a smart tool. By making it better, we are going to do our jobs better and the child is going to participate better,” Behrman said. “We changed it to make the child more accessible to the trainer with good body posture and position for all this repetitive activity.”

Thanks to funding and support from the Coulter Translational Partnership at UofL, the team was able to develop the initial prototype. Behrman and Roussel then collaborated with other specialized manufacturers, further refining the treadmill and harnesses. Once they had a customized treadmill, the team worked to commercialize the device and harness system to make it available to therapists in other centers.

“We starting thinking, ‘How can we make it better?’” Roussel said. “If we are going to move to manufacturing this, how can we make it more modular and with fewer parts that need to be assembled? That’s where the magic and the fun happened.”

The treadmill design was licensed to Power Neurorecovery and units are in place or on their way to facilities in Pittsburgh, Houston and New York, as well as in Louisville at Frazier Rehab Institute.

“In the last several years, we have been able to achieve things that have not historically happened in terms of rehabilitation outcomes for these children,” Behrman said. "Children once unable to sit on their own, for example, can now do so due to locomotor training. Such improvements open up other possibilities to play and engage, and help a child get back on the developmental track. This new treadmill system gives physical therapists and trainers a device that is state-of-the-art in design and utility and revolutionizes the way we deliver locomotor training specifically for children."

 

Thank you to these donors and developers:


Treadmill Donors

  • Christopher and Dana Reeve Foundation
  • Kosair Charities
  • WHAS Crusade for Children
  • Independent Pilots Association Foundation

Treadmill Developers

  • Ty Adams
  • Jena Allen
  • Laura Argetsinger
  • Andrea Behrman
  • Yangsheng Chen
  • Ran Cheng
  • Susan J. Harkema
  • Dena Howland
  • Winston Rauch
  • Tommy Roussel
  • Shelley Trimble
  • Winston Industries
  • Haffendorfer Machine Inc.
  • Tuff Tread Treadmills

Harness Donors

  • WHAS Crusade for Children
  • Rich and Norrie Oelkers and the Bonita Bay Tennis Club

Harness Developers

  • Jenna Allen
  • Laura Argetsinger
  • Andrea Behrman
  • Goose Kearse
  • Rachel Marsilia
  • MacKenzie Roberts
  • Misty Mountain Threadworks

 

Oct. 28, 2019

Pharmacology and Toxicology Graduate Students and Postdocs Win Top Research Presentation Awards

Graduate students and postdocs from the Department of Pharmacology and Toxicology swept nearly all of the PhD and Postdoc presentation awards at the annual Ohio Valley Society of Toxicology meeting held on Friday, October 18 at Procter and Gamble, Inc. in Mason, Ohio.

Jamie Young received the first place award for her platform presentation.  Jamie is a PhD candidate in the laboratory of Professor Lu Cai.

Rachel Speer received the first place award for her poster presentation and third place in the Tox on Clock research presentation.  Rachel is a PhD candidate in the laboratory of Professor John Wise Sr.

Ana Cardoso received the first place award for her platform presentation.  Ana is a postdoctoral fellow in the laboratory of Professor Chris States.

Jennifer Toyoda received the first place award in the Tox on Clock research presentation.  Jennifer is a PhD student in the laboratory of Professor John Wise Sr.

Christine Kim received the second place award for her poster presentation. Christine is a PhD candidate in the laboratory of Professor Brian Ceresa.

Idoia Meaza received the third place award for her poster presentation.  Idoia is a PhD student in the laboratory of Professor John Wise Sr.

Dunbar CAR T-Cell Program to bring more advanced immunotherapy treatment to cancer patients

Dunbar CAR T-Cell Program to bring more advanced immunotherapy treatment to cancer patients

Tom Dunbar with his son, Evan

Cancer patients in Louisville, in Kentucky and throughout the region soon will have access to some of the most advanced immunotherapy treatments available. Louisville resident Thomas E. Dunbar has pledged $1 million to the University of Louisville to create a specialized center to provide chimeric antigen receptor positive T (CAR T) cell therapies to patients at the UofL James Graham Brown Cancer Center and other centers in Kentucky and the Midwest. The new program will be named the Dunbar CAR T-Cell Program.

“This gift will allow both kids and adults to be treated right here in Kentucky with the most innovative cell-based immunotherapy being developed,” said Jason Chesney, M.D., Ph.D., director of the UofL Brown Cancer Center.

See a video of the announcement here.

In CAR T-cell therapies, immune cells are extracted from the patient’s own blood and then are genetically modified to fight cancer. The modified cells are infused back into the patient where they fight the cancer and create long-term immunity to its recurrence. In addition to dramatic treatment results, CAR T-cell immunotherapy leads to fewer toxic side effects than traditional chemotherapy.

“Patients who have been treated with all the conventional therapies who then underwent treatment in clinical trials with CAR T cells had dramatic response rates. Eighty-three percent of kids in the original trial who had lethal, terminal B-cell acute lymphoblastic leukemia responded to this therapy,” Chesney said.

CAR T-cell therapy is FDA approved for treating patients who have B-cell acute lymphoblastic leukemia, who are mostly children, as well as adults who have an adult form of a B-cell (non-Hodgkin’s) lymphoma. This technology also is being tested for treatment of other cancers through clinical trials. Until now however, these treatments have been available primarily in larger coastal cities outside of the Midwestern United States.

“At the UofL Brown Cancer Center, we feel strongly that these advanced therapies should be available not just to people in New York or California or Texas, but to people in Kentucky, Indiana, Tennessee and Illinois. If you live in these areas, it is going to be very hard for you to be treated a thousand miles away with a therapy like this,” Chesney said. “And any patient with health assistance through Medicaid is likely to be covered only if the treatment is delivered within the state.”

The Dunbar CAR T-Cell Program will include laboratories for manufacturing the CAR T cells and will administer both FDA-approved and clinical-trial therapies to adult and pediatric cancer patients. The program intends to expand clinical trials and clinical research using CAR T-cell therapy to treat additional cancer types in Louisville. The goal is for the facilities to be fully functional and receiving patients by Sept. 30, 2020.

Tom Dunbar’s son, Evan, lost his battle to cancer with neuroblastoma in 2001 at the age of 6. In 2009, Wally Dunbar, Tom Dunbar’s father, lost his battle with melanoma. This year, Tom’s physician wife, Stephanie Altobellis, M.D., helped identify his own cancer.

“Kentucky is at ground zero, with the nation’s highest rates of cancer diagnosis and death,” Tom Dunbar said. “It’s completely unacceptable. We have to lead the charge right here where the need is the greatest and we can do the most good. We need treatments that are not toxic. Watching our loved ones miserable with pain, often just from the treatments, and yet still die in front of us simply can’t be the best that we can do.”

How CAR T cells work

T cells are key immune cells in the body that attack cancer cells. CAR T cells are T cells that have been isolated from the patient’s blood and then genetically modified to more effectively destroy the cancer cells.

A non-infectious virus is used to insert genes into the T cells that express a receptor specific to proteins, or antigens, present on cells of the cancer to be treated. The armed, loaded T cell is drawn into close proximity to the cancer cell, and the new cell sends a signal for the T cell to kill the cancer cell.

“We add the receptor gene into the T cells, which makes them stick to the cancer cells like Velcro,” Chesney said. “In theory, all cancers have unique antigens on their surface that we can target with this approach. We are nudging the immune system on to really hit the target, in this case the cancer cells.”

The sophisticated technology requires the use of a specialized clean room for genetically manipulating the patients’ immune cells. The clean rooms, known as Good Manufacturing Practice (GMP) laboratories, require specialized documentation and equipment to protect the individuals working there and ensure a sterile and controlled environment for the cells.

The Dunbar CAR T-Cell Program will include two GMP laboratories, one for use in pediatric therapies to be named for Evan Dunbar and one for adult therapies to be named for Altobellis. These labs are intended to support not only clinical trials and patient treatment at the UofL Brown Cancer Center, but also in other health centers in Louisville, Lexington and elsewhere.

“Our goal for the Dunbar CAR T-Cell Program GMP labs is to be a hub manufacturing facility for CAR T cells, not just in Kentucky, not just in the region, but for the entire country,” Chesney said.

For Dunbar, the goal is to improve cancer treatment for patients.

“The burden is on each of us to create a better future for our children,” Dunbar said. “Working together, we can ensure Louisville is equipped to provide the durable cures, free of side-effects, that we desperately need.”

HSC Research Forum October 29th

CTRB 101/102 from 12 pm - 1 pm.

Topics include: NIH Updates, Sponsored Programs Administration Realignment, KBRIN, Proteomics Core Facility, JHFE Research Enhancement Grants, and more!

UofL research warns millennials of hepatitis C

UofL research warns millennials of hepatitis C

John Myers, Ph.D.

Hepatitis C virus (HCV) infection has skipped a generation and become a predominantly millennial disease, according to research by John Myers, Ph.D., UofL Professor of Pediatrics. 

Myers and his team screened 82,243 individuals for HCV infection in 2016-2018 in Norton Healthcare in order to assess trends in a large health care system in an area with a high prevalence of opioid use and HCV infection. The investigators defined millennials as individuals born between 1980 and 1995, and baby boomers were those born between 1945 and 1965.

Traditionally, baby boomers were the largest drivers of HCV, though millennials have been shown in previous research to be the fastest-growing population of those infected with the virus. However, those studies were performed at single institutions with small sample sizes.

Millennials who were HCV-positive increased by 53 percent over the study period while the population of HCV-positive individuals among baby boomers decreased by 32 percent.

“The opioid crisis has led to a drastic demographic shift, and currently the typical HCV-infected individual is a younger male. Without interventions, this trend will continue for upwards of seven years, plateauing near the demarcation of millennials and generation Z.” Myers said.

The data were presented Oct. 3 in Washington at IDWeek, the combined medical meeting of four adult and pediatric infectious disease societies. 

 

 

 

 

 

 

Professor John Wise Sr. receives education award from Environmental Mutagenesis and Genomics Society

John Wise Sr

 

 

Dr. John Wise Sr., Professor of Pharmacology and Toxicology recently received the EMGS Education Award from the Environmental Mutagenesis and Genomics Society.  The award is bestowed in recognition of sincere dedication to student and young investigator members of the Environmental Mutagenesis and Genomics Society.

Pharmacology & Toxicology PhD candidates receive awards

Two Pharmacology and Toxicology PhD candidates recently received awards. 

Both are supported by T32 predoctoral fellowships on the NIEHS T32 UofL Environmental Health Sciences Training grant.

Jam ie Young received an award to honor her excellent oral presentation at the 13th Conference of International Society for Trace Element Research in Human (ISTERH) at Bali, Indonesia, September 22 – 26, 2019.  Jamie is pursuing her PhD in the laboratory of Professor Lu Cai.




Christine  Kim received a full travel award to attend the 16th Annual APA Environmental Health Scholars Retreat, November 1-3, 2019, in Providence, RI. During the retreat the focus will be on helping you continue to acquire the tools needed to be effective in the field of pediatric environmental health.  Christine is pursuing her PhD in the laboratory of Professor Brian Ceresa.



M&I Ph.D student receives University ExCITE grant

Henry NabetaM& I student Henry Nabeta received an ExCITE award of $50,000 for his project "Developing Q-Griffithsin as a new anti fungal agent".  UofL’s ExCITE program is funded through the National Institute of Health’s Research Evaluation and Commercialization Hub (REACH) program. The goal of the program is to support proof-of-concept centers (hubs) that facilitate and accelerate the translation of biomedical innovations into commercial products that improve patient care and enhance health.

UofL's Clayton Smith named Best Doctor by LEO Weekly

UofL's Clayton Smith named Best Doctor by LEO Weekly

Clayton M. Smith, M.D.

Clayton M. Smith, M.D., associate professor of medicine in the UofL School of Medicine and internal medicine physician with UofL Physicians, has received 1st place, Best Doctor in LEO Weekly’s Readers’ Choice Awards, winning over more than 100 nominees. Smith focuses his clinical practice on primary care internal medicine and LGBTQ health. He will be honored Oct. 3 at the Readers’ Choice Awards Party. 

See the LEO Readers Choice Awards list here.

NCI Cancer Education Program participants receive awards at Research!Louisville

NCI Cancer Education Program participants received best research poster awards at Research!Louisville held September 13, 2019:

Norbert J. Burzynski Award Professional Student Category

 

1st place:  Ankur Patel 

ZEB mRNA Expression is Affected by Long Non-coding RNA ZFAS1

Mentor: Susan Galandiuk

 

2nd place:  James Burton 

Effect of Long Non-Coding RNA ZFAS1 on Epithelial-To-Mesenchymal Transition Protein Expression in Colorectal Cancer Cell Lines 

Mentor:  Susan Galandiuk

 

3rd place: Daniel Hodge 

The effects of arylamine N-acetyltransferase 1 on tumor immune response

Mentor: David Hein

 

Norbert J. Burzynski Award Undergraduate Student Category


1st place:  Grace Lian

Investigating molecules that confer sensitivity to AS1411 in lung adenocarcinoma cells

Mentor: Paula Bates

 

2nd place:  Kate Tarvestad

Low-Level Chronic Arsenic Exposure and its Effect on the ErbB Family Receptor Tyrosine Kinases.

Mentor:  Brian Ceresa

 

3rd place:  Destine Ede 

A Potential Novel Treatment for Neurofibromatosis Type 1 via RAS Inhibition 

Mentor: Geoffrey Clark

 

Pharmacology and Toxicology graduate students receive awards at Research!Louisville

Department of Pharmacology and Toxicology graduate students received awards for best research poster presentations at Research!Louisville on September 13, 2019.  

Master’s Basic Science Graduate Student Awards

 1st place:  Jeffrey Warner

“Soluble epoxide hydrolase inhibition: a novel therapeutic strategy in alcoholic liver disease”  

Mentor: Irina Kirpich

 

2nd place:  Sean Raph

“KVß2 mediates vasodilation in response to redox changes of the NADH:NAD+ ratio.”

Mentor: Matthew Nystoriak.

 

2nd place:  Angeliki Lykoudi 

“Overexpression of has-miR-186 induces anchorage-independent growth and chromosomal alterations in arsenic exposed human keratinocytes: A preliminary study”

Mentor: J. Christopher States

 

Doctoral Basic Science Graduate Student Awards

3rd place:  Adrienne Bushau-Sprinkle 

“Mechanistic insight for increased susceptibility to cisplatin nephrotoxicity with NHERF1 loss”. 

Mentor: Eleanor Lederer

 

"Write Winning Grant Proposals" Seminar

Seminar sponsored by the Kentucky Pediatric IDeA Grant Research Center (K-PIRC).

Wednesday, January 22, 2020, 8:30am - 4:30pm, HSC location TBD. Seminar is free, but registration is required: https://www.eventbrite.com/e/write-winning-grant-proposals-tickets-71511421587. Registration will close Friday, January 3rd. For more info contact Jackie Boyd at 502.588.0774 or

DOM members make impressive showing at 2019 Research!Louisville

Annual event held at the University of Louisville highlights, promotes excellence and public awareness of health sciences research at the Louisville Medical Center
DOM members make impressive showing at 2019 Research!Louisville

Ming Song, Ph.D., of the UofL Division of Gastroenterology, Hepatology & Nutirtion accepts his 1st place award in the Faculty Award in Basic Science category at the recent 2019 Research!Louisville

VIEW A PHOTO GALLERY FROM 2019 Research!Louisville

It's become a tradition for members and affiliates of the University of Louisville Department of Medicine to make an impact at the annual Research!Louisville competition at UofL, and 2019 was no exception.

Celebrating its 24th year, Research!Louisville is an annual celebration of health-related research aimed at promoting excellence and public awareness in health sciences research in Louisville while also generating additional funding for health sciences research.

A panel of university faculty judges selected the winners of this year's contest from hundreds of entries in the categories of professional/clinical students, basic science grad students, postgraduates and faculty.

"The research performed by members of the Department of Medicine is second to none," Dr. Eleanor Lederer, interim chair of the UofL Department of Medicine said. "Research!Louisville gives our Department the opportunity to showcase the important investigative work we do every day."

Here's a look at finished at or near the top in their respective categories:

Master’s Basic Science Graduate Student Award

  • 2nd place: Sean Raph - "KVß2 mediates vasodilation in response to redox changes of the NADH:NAD+ ratio"
    Mentor: Matthew Nystoriak
  • 1st place: Jeffrey Warner - "Soluble epoxide hydrolase inhibition: a novel therapeutic strategy in alcoholic liver disease"
    Mentor: Irina Kirpich

Doctoral Basic Science Graduate Student Award

  • 3rd place: Adrienne Bashau-Sprinkle - "Mechanistic insight for increased susceptibility to cisplatin nephrotoxicity with NHERF1 loss"
    Mentor: Eleanor Lederer

Engineering Student Award

  • 3rd place: Alexa Melvin - "A 3D Printed Microfluidic Manifold to Prepare Plasma from Whole Blood"
    Mentor: Nichola Garbett

Postdoctoral Fellow Award

  • 2nd place: Josiah Hardesty - "Genetic ablation of Fpr2 in mice increased susceptibility to alcohol-mediated liver injury due to enhanced inflammation and impaired antimicrobial defense"
    Mentor: Irina Kirpich
  • 1st place: Banrida Wahlang - "Hepatic injury caused by the environmental toxicant vinyl chloride is sex-dependent"
    Mentor: Matthew Cave

Faculty Award in Basic Science

  • Winner: Ming Song - "Dietary Fructose Induces Intestinal Oxygenation Likely Contributing to Gut Microbiota Dysbiosis"

Ruth Greenberg Award for Excellence in Medical Education Research

  • 3rd place: Barbara Head - "Does faculty training and development improve skills and competencies that lead to interprofessional educational programs in palliative care? he iPEX Program"

Louisville Chapter-Women in Medicine and Science

  • 3rd place: Lilibeth Lanceta - "Oncolytic Virotherapy for the treatment of ER+ palbociclib-resistant breast cancer"
    Mentor: Yoannis Imbert-Fernandez
  • 2nd place: Smita Ghare - "Tributyrin attenuates alcohol-induced chemokine up-regulation via epigenetic mechanisms - Relevance to hepatic inflammation and Injury in ALD"
    Mentor: Shirish Barve

Prodigy Award for High School Translational Research

  • 2nd Place: Maxwell Martin - "Automation of DNA-ligand MD simulations with free energy calculations for enrichment of high affinity ligands in virtual screening"
    Mentor: John Trent

NCI Cancer Education Program Norbert J. Burzynski Award Undergraduate Student Category

  • 1st place: Grace Lian - "Investigating molecules that confer sensitivity to AS1411 in lung adenocarcinoma cells"
    Mentor: Paula Bates

30 Pharmacology & Toxicology graduate students presenting their research posters at Research!Louisville

30 Pharmacology & Toxicology graduate students are presenting their research posters at Research!Louisville Tuesday morning September 10 from 9-am to noon in the Kosair Charities Clinical and Translational Research Building.

Over 40 NCI Cancer Education Program participants will present their research posters at Research!Louisville

Over 40 NCI Cancer Education Program participants will present their research posters at Research!Louisville.  The posters are available here.

The NCI cancer education program selects professional and undergraduate students from the University of Louisville and other universities across the USA.  Further information is available at http://uofl.me/nci-r25.

UofL Liver Researchers included in "Best of the Liver Meeting" at AASLD Annual Meeting

Congratulations to our Liver Researchers—two of the many abstracts from our group that were submitted to and accepted for presentation at the annual meeting of the American Association for the Study of Liver Diseases have been chosen for inclusion in the “Best of the Liver Meeting” summary slide deck in the Alcohol-Related Liver Disease Category.  These are:  

1.  Keratin 18 is a Biomarker for the Diagnosis and Prognosis in Acute Alcoholic Hepatitis. (Vatsalya Vatsalya, Matthew C Cave, Maiying Kong, Leila Gobejishvili, Heather Clair, Cameron Falkner, John Craycroft, Mack C Mitchell, Gyongyi Szabo, Arthur J McCullough, Srinivasan Dasarathy, Svetlana Radaeva, Bruce Barton and Craig J McClain)

2.  Fpr2-/- Mice Are More Susceptible to Alcohol-Induced Liver Injury Due to Impaired Antimicrobial Defense. (Josiah E Hardesty, Jeffrey B Warner, Dennis R Warner, Ying Song, Craig J McClain, Irina A Kirpich).

Department Welcomes Incoming Students of 2019

Monday, August 12, the Department of Microbiology & Immunology welcomed  the incoming M&I graduate students with a luncheon in the CTRB.  Incoming students include Richard Bautista, Easton Ford, Kamille Rasche, Omar Sarker, Caleb Whitley and Matthew Woeste.

2019 New student orientation lunch.                

M&I PhD Candidate receives NIH F31 award

PriceSarah Price, a graduate student in the laboratory of Dr. Matthew Lawrenz, has been awarded a Ruth L. Kirschstein Predoctoral Individual National Research Service Award (F31) from the National Institute of Allergy and Infectious Diseases for her PhD research entitled “Identification of a novel zinc acquisition system in Yersinia pestis”. This three year fellowship will support Sarah’s research in the field of nutritional immunity.

 

                                     

Rare Disease Day (8/2/19)

August 2, 2019 was proclaimed as Rare Diseases Day in Kentucky.  Gov. Bevin made the proclamation at the University of Louisville.  He was accompanied by Dr. Thomas Abell, Director of GI Motility in the UofL School of Medicine.  Dr. Abell studies gastroparesis, a rare disease, and is considered to be a world authority on the condition.